Stereocontrolled Synthesis of Arylomycin-Based Gram-Negative Antibiotic GDC-5338.

Org Lett

Department of Small Molecule Process Chemistry , Genentech, Inc. , 1 DNA Way , South San Francisco , California 94080 , United States.

Published: November 2019

We report herein an efficient, stereocontrolled, and chromatography-free synthesis of the novel broad spectrum antibiotic . The route features the construction of a functionalized tripeptide backbone, a high-yielding macrocyclization via a Pd-catalyzed Suzuki-Miyaura reaction, and the late-stage elaboration of key amide bonds with minimal stereochemical erosion. Through extensive reaction development and analytical understanding, these key advancements allowed the preparation of in 17 steps, 15% overall yield, >99 A % HPLC, and >99:1 dr.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.orglett.9b03481DOI Listing

Publication Analysis

Top Keywords

stereocontrolled synthesis
4
synthesis arylomycin-based
4
arylomycin-based gram-negative
4
gram-negative antibiotic
4
antibiotic gdc-5338
4
gdc-5338 report
4
report efficient
4
efficient stereocontrolled
4
stereocontrolled chromatography-free
4
chromatography-free synthesis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!